Form 8-K - Current report:
SEC Accession No. 0000950170-25-088700
Filing Date
2025-06-23
Accepted
2025-06-23 06:32:13
Documents
80
Period of Report
2025-06-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K catx-20250621.htm   iXBRL 8-K 52018
2 EX-99.1 catx-ex99_1.htm EX-99.1 26684
3 EX-99.2 catx-ex99_2.htm EX-99.2 48413
4 EX-99.3 catx-ex99_3.htm EX-99.3 14886
5 EX-99.4 catx-ex99_4.htm EX-99.4 20649
6 GRAPHIC img236230851_0.jpg GRAPHIC 57883
7 GRAPHIC img237154372_0.jpg GRAPHIC 57883
8 GRAPHIC catx-ex99_3s1.jpg GRAPHIC 893939
9 GRAPHIC catx-ex99_4s1.jpg GRAPHIC 132545
10 GRAPHIC catx-ex99_4s2.jpg GRAPHIC 542847
11 GRAPHIC catx-ex99_4s3.jpg GRAPHIC 273965
12 GRAPHIC catx-ex99_4s4.jpg GRAPHIC 197558
13 GRAPHIC catx-ex99_4s5.jpg GRAPHIC 244316
14 GRAPHIC catx-ex99_4s6.jpg GRAPHIC 295093
15 GRAPHIC catx-ex99_4s7.jpg GRAPHIC 249159
16 GRAPHIC catx-ex99_4s8.jpg GRAPHIC 111345
17 GRAPHIC catx-ex99_4s9.jpg GRAPHIC 256130
18 GRAPHIC catx-ex99_4s10.jpg GRAPHIC 280309
19 GRAPHIC catx-ex99_4s11.jpg GRAPHIC 345371
20 GRAPHIC catx-ex99_4s12.jpg GRAPHIC 247651
21 GRAPHIC catx-ex99_4s13.jpg GRAPHIC 350780
22 GRAPHIC catx-ex99_4s14.jpg GRAPHIC 267674
23 GRAPHIC catx-ex99_4s15.jpg GRAPHIC 264604
24 GRAPHIC catx-ex99_4s16.jpg GRAPHIC 134673
25 GRAPHIC catx-ex99_4s17.jpg GRAPHIC 233010
26 GRAPHIC catx-ex99_4s18.jpg GRAPHIC 402122
27 GRAPHIC catx-ex99_4s19.jpg GRAPHIC 123156
28 GRAPHIC catx-ex99_4s20.jpg GRAPHIC 305140
29 GRAPHIC catx-ex99_4s21.jpg GRAPHIC 323554
30 GRAPHIC catx-ex99_4s22.jpg GRAPHIC 211933
31 GRAPHIC catx-ex99_4s23.jpg GRAPHIC 326650
32 GRAPHIC catx-ex99_4s24.jpg GRAPHIC 211011
33 GRAPHIC catx-ex99_4s25.jpg GRAPHIC 268154
34 GRAPHIC catx-ex99_4s26.jpg GRAPHIC 396982
35 GRAPHIC catx-ex99_4s27.jpg GRAPHIC 207147
36 GRAPHIC catx-ex99_4s28.jpg GRAPHIC 346192
37 GRAPHIC catx-ex99_4s29.jpg GRAPHIC 272755
38 GRAPHIC catx-ex99_4s30.jpg GRAPHIC 124096
39 GRAPHIC catx-ex99_4s31.jpg GRAPHIC 264270
40 GRAPHIC catx-ex99_4s32.jpg GRAPHIC 318311
41 GRAPHIC catx-ex99_4s33.jpg GRAPHIC 321419
42 GRAPHIC catx-ex99_4s34.jpg GRAPHIC 218997
43 GRAPHIC catx-ex99_4s35.jpg GRAPHIC 358863
44 GRAPHIC catx-ex99_4s36.jpg GRAPHIC 253613
45 GRAPHIC catx-ex99_4s37.jpg GRAPHIC 261432
46 GRAPHIC catx-ex99_4s38.jpg GRAPHIC 305199
47 GRAPHIC catx-ex99_4s39.jpg GRAPHIC 136769
48 GRAPHIC catx-ex99_4s40.jpg GRAPHIC 297312
49 GRAPHIC catx-ex99_4s41.jpg GRAPHIC 309042
50 GRAPHIC catx-ex99_4s42.jpg GRAPHIC 293393
51 GRAPHIC catx-ex99_4s43.jpg GRAPHIC 233666
52 GRAPHIC catx-ex99_4s44.jpg GRAPHIC 217010
53 GRAPHIC catx-ex99_4s45.jpg GRAPHIC 223335
54 GRAPHIC catx-ex99_4s46.jpg GRAPHIC 319037
55 GRAPHIC catx-ex99_4s47.jpg GRAPHIC 281040
56 GRAPHIC catx-ex99_4s48.jpg GRAPHIC 97587
57 GRAPHIC catx-ex99_4s49.jpg GRAPHIC 266900
58 GRAPHIC catx-ex99_4s50.jpg GRAPHIC 237518
59 GRAPHIC catx-ex99_4s51.jpg GRAPHIC 219519
60 GRAPHIC catx-ex99_4s52.jpg GRAPHIC 99177
61 GRAPHIC catx-ex99_4s53.jpg GRAPHIC 289442
62 GRAPHIC catx-ex99_4s54.jpg GRAPHIC 86547
63 GRAPHIC catx-ex99_4s55.jpg GRAPHIC 352270
64 GRAPHIC catx-ex99_4s56.jpg GRAPHIC 309818
65 GRAPHIC catx-ex99_4s57.jpg GRAPHIC 304449
66 GRAPHIC catx-ex99_4s58.jpg GRAPHIC 225038
67 GRAPHIC catx-ex99_4s59.jpg GRAPHIC 231623
68 GRAPHIC catx-ex99_4s60.jpg GRAPHIC 309749
69 GRAPHIC catx-ex99_4s61.jpg GRAPHIC 328207
70 GRAPHIC catx-ex99_4s62.jpg GRAPHIC 244369
71 GRAPHIC catx-ex99_4s63.jpg GRAPHIC 312785
  Complete submission text file 0000950170-25-088700.txt   24372215

Data Files

Seq Description Document Type Size
72 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT catx-20250621.xsd EX-101.SCH 25913
82 EXTRACTED XBRL INSTANCE DOCUMENT catx-20250621_htm.xml XML 4918
Mailing Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121
Business Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121 206-676-0900
Perspective Therapeutics, Inc. (Filer) CIK: 0000728387 (see all company filings)

EIN.: 411458152 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33407 | Film No.: 251062908
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)